Key Dates

Related Announcements

RFA-DA-21-020 - HEAL Initiative: HEALthy Brain and Child Development Study (Collaborative U01 Clinical Trial Not Allowed)

RFA-DA-21-021 - HEAL Initiative: HEALthy Brain and Child Development Study (U01 Clinical Trial Not Allowed)

RFA-DA-21-022 - HEAL Initiative: HEALthy Brain and Child Development Consortium Administrative Core (U24 Clinical Trial Not Allowed)

RFA-DA-21-023 - HEAL Initiative: HEALthy Brain and Child Development Data Coordinating Center (U24)

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

On January 11, 2021, the NIH issued the following Funding Opportunity Announcements (FOAs):

1. RFA-DA-21-020 - HEAL Initiative: HEALthy Brain and Child Development Study (Collaborative U01- Clinical Trial Not Allowed)
2. RFA-DA-21-021 - HEAL Initiative: HEALthy Brain and Child Development Study (U01 - Clinical Trial Not Allowed)
3. RFA-DA-21-022 - HEAL Initiative: HEALthy Brain and Child Development Consortium Administrative Core (U24 - Clinical Trial Not Allowed)
4. RFA-DA-21-023 - HEAL Initiative: HEALthy Brain and Child Development Data Coordinating Center (U24)

Webinar Information
Date: February 10, 2021
Time: 11:00 – 12:30 pm ET

The intent of the pre-application webinar is to provide an overview of RFA-DA-21-020, RFA-DA-21-021, RFA-DA-21-022, and RFA-DA-21-023,  identify areas of synergies and distinctions between the funding opportunities, and to address questions from potential applicants. The webinar is optional and not required for application submission. The webinar may conclude before the scheduled time depending on the number of questions.

Additional information, including a link to register for the webinar will be posted at:

https://www.drugabuse.gov/news-events/meetings-events/2021/02/hbcd-technical-assistance-webinar. Following the webinar, the slides presented during the webinar will be posted on the same website. Prospective applicants with inquiries concerning the FOAs who are unable to participate in the webinar are encouraged to view the summary of questions and answers after the webinar.

FAQs
FAQs will be posted on the same website with a summary of questions and answers from the webinar and may be updated with additional questions and answers without further notice.

Inquiries

Please direct all inquiries to:

Minki Chatterji, Ph.D.
National Institute on Drug Abuse (NIDA)
Email: minki.chatterji@nih.gov

Michelle Freund, Ph.D.
National Institute on Drug Abuse (NIDA Email): freundm@mail.nih.gov